Aerosolized, recombinant Alpha 1-Antitrypsin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aerosolized, recombinant Alpha 1-Antitrypsin, covering 2021-05-05 to 2021-05-05. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency [Phase 1, Phase 2]